Baruch Lev
Accounting · 2000–2018
A researcher in the Science corpus: 28 papers; trusts 75 researchers and is trusted by 110 researchers here, as inferred from the citation graph.
Subfields
- Accounting — 222 citations into it; #365 of 8,981 by trust here, #235 by citations
- Finance — 142 citations into it; #1,163 of 10,547 by trust here, #485 by citations
- Strategy and Management — 107 citations into it; #500 of 10,880 by trust here, #365 by citations
- Economics and Econometrics — 48 citations into it; #10,337 of 23,545 by trust here, #6,701 by citations
- Management Science and Operations Research — 12 citations into it; #11,543 of 12,201 by trust here, #7,114 by citations
Whom Baruch Lev trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Eugene F. Fama
- Ilia D. Dichev
- Paul Hribar
- R. Peters
- Stephen H. Penman
- Halbert White
- Patricia M. Dechow
- Lillian F. Mills
- Cristi A. Gleason
- Michelle Hanlon
Who trusts Baruch Lev overall
- Bernard Marr
- V. Beattie
- Caroline Flammer
- Matteo Pedrini
- Dechun Wang
- Daniel Zéghal
- Mostafa Monzur Hasan
- Helen Kang
- Shivaram Rajgopal
- Feng Gu
Papers from Baruch Lev's perspective
Ordered by how strongly the researchers Baruch Lev trusts endorse each paper. Same corpus, a different order for every researcher.
- Costs of Equity and Earnings Attributes
- The Cross‐Section of Expected Stock Returns
- Managing with Style: The Effect of Managers on Firm Policies
- The Quality of Accruals and Earnings: The Role of Accrual Estimation Errors
- Errors in Estimating Accruals: Implications for Empirical Research
- Common risk factors in the returns on stocks and bonds
- The market pricing of accruals quality
- Determinants of Market Reactions to Restatement Announcements
- Discussion of the Quality of Accruals and Earnings: The Role of Accrual Estimation Errors
- Audit committee, board of director characteristics, and earnings management
Their papers
- Competitive Costs of Disclosure by Biotech IPOs (2004) — 335 citations
- The Persistence of the Accruals Anomaly (2006) — 184 citations
- The Valuation of Organization Capital (2005) — 221 citations
- The Valuation of Biotech IPOs (2005) — 146 citations
- The deteriorating usefulness of financial report information and how to reverse it (2018) — 189 citations
- On Guidance and Volatility (2015) — 125 citations
- Managerial Ability and Earnings Quality (2013) — 977 citations
- Quantifying Managerial Ability: A New Measure and Validity Tests (2012) — 1,660 citations
- Overpriced Shares, Ill-Advised Acquisitions, and Goodwill Impairment (2011) — 269 citations
- Intangible Assets: Measurement, Drivers, and Usefulness (2011) — 113 citations
- The usefulness of accounting estimates for predicting cash flows and earnings (2010) — 154 citations
- To Guide or Not to Guide? Causes and Consequences of Stopping Quarterly Earnings Guidance*: Causes and Consequences of Stopping Quarterly Earnings Guidance (2010) — 175 citations
- Is Doing Good Good for You? How Corporate Charitable Contributions Enhance Revenue Growth (2009) — 917 citations
- To Guide Or Not to Guide? Causes and Consequences of Stopping Quarterly Earnings Guidance (2008) — 205 citations
- Executive pay dispersion, corporate governance, and firm performance (2008) — 232 citations
- Explaining the Short- and Long-Term IPO Anomalies in the US by R&D (2006) — 158 citations
- R&D Reporting Biases and Their Consequences (2005) — 326 citations
- The dominance of intangible assets: consequences for enterprise management and corporate reporting (2004) — 207 citations
- Changes in Institutional Ownership and Subsequent Earnings Announcement Abnormal Returns (2004) — 133 citations
- Taxable Income, Future Earnings, and Equity Values (2004) — 460 citations